Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF
Status:
Completed
Trial end date:
2020-04-07
Target enrollment:
Participant gender:
Summary
Phase 2 study to evaluate the efficacy and safety of intermittent levosimendan compared with
placebo in hemodynamic improvement with exercise in PH-HFpEF subjects